Safety and Efficacy of Treatment with Sofosbuvir+GS-5816 +/- Ribavirin for 8 or 12 Weeks in Treatment Naive Patients with Genotype 1-6 HCV InfectionTram T. Tran,Timothy R. Morgan,Paul J. Thuluvath,Kyle Etzkorn,Federico Hinestrosa,Myron Tong,John McNally,Diana M. Brainard,Lingling Han,Brian Doehle,Erik Mogalian,John G. McHutchison,Raymond T. Chung,Gregory T. EversonHEPATOLOGY（2014）引用 0|浏览15暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
